No abstract

No abstract

No abstract

Two analytical methods were developed and refined for the detection and quantitation of two groups of endocrine-disrupting chemicals (EDCs) in the liquid matrixes of two pilot-scale municipal wastewater treatment plants. The targeted compounds are seven sex hormones (estradiol, ethinylestradiol, estrone, estriol, testosterone, progesterone, and androstenedione), a group of nonionic surfactants (nonylphenol polyethoxylates), and their biodegradation byproducts nonylphenol and nonylphenol ethoxylates with one, two, and three ethoxylates. Solid phase extraction using C-18 for steroids and graphitized carbon black for the surfactants were used for extraction. HPLC-DAD and GC/MS were used for quantification. Each of the two 20 L/h pilot-scale plants consists of a primary settling tank followed by a three-stage aeration tank and final clarification. The primary and the waste-activated sludge are digested anaerobically in one plant and aerobically in the other. The pilot plants are fed with a complex synthetic wastewater spiked with the EDCs. Once steady state was reached, liquid samples were collected from four sampling points to obtain the profile for all EDCs along the treatment system. Complete removal from the aqueous phase was obtained for testosterone, androstenedione, and progesterone. Removals for nonylphenol polyethoxylates, estradiol, estrone, and ethinylestradiol from the aqueous phase exceeded 96%, 94%, 52%, and 50%, respectively. Levels of E3 in the liquid phase were low, and no clear conclusions could be drawn concerning its removal.

The aquatic environment can contain numerous micropollutants and there are concerns about endocrine activity in environmental waters and the potential impacts on human and ecosystem health. In this study a complementary chemical analysis and in vitro bioassay approach was applied to evaluate endocrine activity in treated wastewater, surface water and drinking water samples from six countries (Germany, Australia, France, South Africa, the Netherlands and Spain). The bioassay test battery included assays indicative of seven endocrine pathways, while 58 different chemicals, including pesticides, pharmaceuticals and industrial compounds, were analysed by targeted chemical analysis. Endocrine activity was below the limit of quantification for most water samples, with only two of six treated wastewater samples and two of six surface water samples exhibiting estrogenic, glucocorticoid, progestagenic and/or anti-mineralocorticoid activity above the limit of quantification. Based on available effect-based trigger values (EBT) for estrogenic and glucocorticoid activity, some of the wastewater and surface water samples were found to exceed the EBT, suggesting these environmental waters may pose a potential risk to ecosystem health. In contrast, the lack of bioassay activity and low detected chemical concentrations in the drinking water samples do not suggest a risk to human endocrine health, with all samples below the relevant EBTs.